Wiehle Ronald 4
4 · REPROS THERAPEUTICS INC. · Filed Mar 2, 2011
Insider Transaction Report
Form 4
Wiehle Ronald
Vice President, R&D
Transactions
- Award
Stock Option
2011-02-28+100,000→ 100,000 totalExercise: $4.50Exp: 2021-02-28→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable at a rate of 1/12th per quarter for a period of 3 years.